In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...

Cognitive assessments, brain scans and blood tests are often used to diagnose Alzheimer’s because no single test is definitive. One exam, a tau PET scan, relies on a radioactive tracer injected ...

PET scan: This shows the activity in your brain and can be used to check for the amyloid protein, which can be a sign of Alzheimer's disease. Your doctor will ask questions about your mood and ...

A recent study provided key insights into brain degeneration in DLB, which may help clinicians better monitor this ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...

A new study has found that women with high levels of β-amyloid (Aβ), a protein linked to Alzheimer’s disease, experience ...

The mean age at the first tau scan was 71.9 years ... et al "Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis" JAMA Neurol 2025; DOI: 10.1001/jamaneurol.